Journals / Marmara Pharmaceutical Journal / 2017 / Cilt: 21 - Sayı: 2

A Retrospective Qualitative Study on Current Diabetic Foot Ulcer Management and Discussion on Extended Role of Clinical Pharmacist

Pages
412–418
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

It was found that 60.5% of the patients having at least one co-morbid condition and 90.6% of patients possess one or more risk factors to develop diabetic foot ulcers.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Diabetic foot ulcers (DFU) are chronic complications due to poor diabetic control.
📊
Key Findings & Data:The study revealed that diabetic foot ulcer was more prevalent among male patients with type 2 diabetes since 11 to 25 yrs belongs to the age group between 51-60 years.
💡
Conclusion & Impact:It was found that 60.5% of the patients having at least one co-morbid condition and 90.6% of patients possess one or more risk factors to develop diabetic foot ulcers.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Diabetic foot ulcers (DFU) are chronic complications due to poor diabetic control. Diabetic foot ulcers can lead to lifelong disability and substantially diminish the quality of life. The aim of this study was to carry out a thorough evaluation of diabetic foot ulcer management, compare current scenario of DFUs care with the International guidelines and to identify the extended roles of clinical pharmacist to improve the conditions of diabetic patient with foot ulcers. It is a retrospective qualitative study carried out in two tertiary care hospitals of Tamil Nadu state. The patients were selected based on inclusion and exclusion criteria admitted in the hospitals with diabetic foot ulcers. The patient’s socio- demographic and clinical characteristics tools from the patient medication records (PMR) were collected and taken into considerations for the study. The study revealed that diabetic foot ulcer was more prevalent among male patients with type 2 diabetes since 11 to 25 yrs belongs to the age group between 51-60 years. It was found that 60.5% of the patients having at least one co-morbid condition and 90.6% of patients possess one or more risk factors to develop diabetic foot ulcers. Glycated hemoglobin (HbA 1c ) test were done only by 54.7% of the patients, which showed that it was not insisted as an important identification tool for diabetic foot ulcer. The PMR revealed numerous antibiotics switch-over for the wound treatment as well. From the study it was concluded that an immediate requirement and thorough evaluation of enhanced foot care management, patient centered care and diabetic foot surveillance etc is needed for diabetic foot ulcer management. A comparative current scenario of DFUs care with the International guidelines and its adaptation and modifications according to our need is to be emphasized. Amalgamation of clinical pharmacy services with the multidisciplinary diabetic foot care team services is to be made. The clinical pharmacist’s intervention is to be put forward to improve the conditions of diabetic patient with foot ulcers to decrease the alarming incidences in Indian hospital settings.

🔖

Cite This Article

PORSELVİ, A., SHANKAR, M. S. U., LAKSHMİ, K. S., SANKAR, V. (2017). A Retrospective Qualitative Study on Current Diabetic Foot Ulcer Management and Discussion on Extended Role of Clinical Pharmacist. Marmara Pharmaceutical Journal, Cilt: 21 - Sayı: 2, 412–418. https://ajindex.com/articles/283729

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (9)

  1. World Health Organization. Definition, Diagnosis andClassification of Diabetes Mellitus and its complications. Part1: Diagnosis and Classification of Diabetes Mellitus. WHO/NCD/NCS/99.2 ed. Geneva, World Health Organisation1999.
  2. Palumbo PJ, Melton Lj. III. Peripheral vascular disease anddiabetes. In: Diabetes in America. Harris MI, Hamman RF.US Government Printing Office, Washington DC. 1985; 1-21. Reiber GE. The epidemiology of diabetic foot problems.Diabet Med 1996; 13:S6-S11. Bartus CL, Margolis DJ. Reducing the incidence of footulceration and amputation in diabetes. Curr Diab Rep. 2004;4: 413–8.
  3. Bild DE, Selby JV, Sinnock P, Browner WS, Braveman P,Showstack JA. Lower- extremity amputation in people withDiabetes epidemiology and prevention. Diabetes Care 1989:12: 24-31. Edmonds ME. Progress in care of the diabetic foot. Lancet1999: 354: 270-2.
  4. Wild S, Roglic G, Green A, Sieree R King H. Global prevalenceof diabetes: estimates for the year 2000 and projections for2030. Diabetes Care 2004; 27:1047-53. International Diabetes Federation. IDF Atlas, 4th ed. Brusels,Belgium. 2009.
  5. Vijay Snehalatha C, Terin M, Ramachandran A. Socio-culturalpractices that may affect the development of the diabetic foot.IDF Bull 1997: 42; 10-2.
  6. Alonso-Fernandez M, Mancera-Romero J, Mediavilla-BravoJJ, Comas-Samper JM, Lopez-Simarro F, Perez-UnanuaMP, Iturralde-Iriso J; Work Group of Diabetes SEMERGEN(Sociedad Espanola de Medicos de Atencion Primaria).Glycemic Control and Use of A1c In Primary Care PatientsWith Type 2 Diabetes Mellitus. Primary care Diabetes 2015;9: 385-91. Brod M. Quality of life issues in patients with diabetes andlower extremity ulcers: Patients and care givers. Qual Life Res1998; 7: 365-72.
  7. Popkin BM, Gordon- Larsen P. The nutrition transition:Worldwide obesity dynamics and their determinants. Int JObes Relat Metab Disord. 2004; Suppl.3: S2-S9. Unwin N. The diabetic foot in the developing world. DiabetesMetab Res Rev 2008; 24- Suppl I: S31-S33. Jeffcoate WJ, Harding KG. Diabetic foot ulcers. Lancet 2003;361: 1545-51.
  8. Boulton AJ, Vleikyte L, Ragnarson- Tennvall G, Apelqvist J.The global burden of diabetic foot disease. Lancet 2005; 366:1719-24.
  9. Abol Hassani F, Mohajeri Tehrani MR, Tabatabaei O, LarijaniB. Burden of diabetes and its complications in Iran in the year 2000. Iran J Diabetes and Lipid Disord 2005; 5:35-48. Reiber GE. The Epidemiology of diabetic foot problems.Diabet Med 1996; 13: S6-S11. Al-wahbi AM. Impact of diabetic education program on lowerlim